Report: Pharma Could Game Favored-Nation Policy

By Ariel Cohen / September 1, 2020 at 12:00 AM
The president’s plan for Medicare to pay no more for prescription drugs than the governments of other developed countries may not work in some instances because drug companies could find ways to sell drugs here that aren’t available abroad and therefore don’t have an international reference price, according to drug price watchdog 46Brooklyn. However, one of the potential tactics that 46Brooklyn said drug companies might use -- charging other countries more to boost reference prices -- is a goal of...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.